Get the Stockscreener App
0.4107
5.17%
-0.0224
After Hours:
.43
0.0193
+4.70%
Fractyl Health Inc stock is traded at $0.4107, with a volume of 3.46M.
It is down -5.17% in the last 24 hours and down -79.47% over the past month.
Fractyl Health Inc is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including type 2 diabetes and obesity. The company focuses on transforming metabolic disease treatment from chronic symptomatic management to durable disease modifying therapies that target the organ level root causes of T2D and obesity.
See More
Previous Close:
$0.4331
Open:
$0.44
24h Volume:
3.46M
Relative Volume:
0.60
Market Cap:
$62.99M
Revenue:
-
Net Income/Loss:
$-56.85M
P/E Ratio:
-0.2634
EPS:
-1.559
Net Cash Flow:
-
1W Performance:
+2.67%
1M Performance:
-79.47%
6M Performance:
-58.26%
1Y Performance:
-72.25%
1-Day Range:
$0.4071
$0.44
1-Week Range:
$0.3901
$0.4953
52-Week Range:
$0.3772
$3.03
Fractyl Health Inc Stock (GUTS) Company Profile
Name
Fractyl Health Inc
Sector
Industry
Phone
781-902-8800
Address
3 VAN DE GRAAFF DRIVE, BURLINGTON
Compare GUTS vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GUTS
Fractyl Health Inc
|
0.4107 | 66.43M | 0 | -56.85M | 0 | -1.559 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
Fractyl Health Inc Stock (GUTS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-30-26 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Sep-15-25 | Initiated | H.C. Wainwright | Buy |
| Aug-28-25 | Initiated | Ladenburg Thalmann | Buy |
| Feb-28-24 | Initiated | Evercore ISI | Outperform |
| Feb-27-24 | Initiated | BofA Securities | Buy |
| Feb-27-24 | Initiated | Morgan Stanley | Overweight |
View All
Fractyl Health Inc Stock (GUTS) Latest News
Insider Sell: What is the dividend yield of Fractyl Health IncJuly 2025 Final Week & AI Driven Price Predictions - baoquankhu1.vn
Risk Off: How correlated is Fractyl Health Inc to the S P500Quarterly Trade Report & Community Consensus Trade Signals - baoquankhu1.vn
Aug Technicals: Does Fractyl Health Inc have pricing powerJuly 2025 EndofMonth & Long Hold Capital Preservation Plans - baoquankhu1.vn
Fractyl Health, Inc. (NASDAQ:GUTS) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Even endpoint hits don’t spare shares in three weight-loss updates - biocentury.com
Why Fractyl Health Inc. stock remains a top recommendationJuly 2025 Recap & Expert Approved Trade Ideas - mfd.ru
Market Trends: Is Fractyl Health Inc benefiting from interest rate changesJuly 2025 Sector Moves & Free Reliable Trade Execution Plans - baoquankhu1.vn
Fractyl Health: Unreasonably Low Market Expectations Create A Trading Opportunity Towards 2026 Catalysts - Seeking Alpha
Fractyl Health plummets on data for Revita for weight loss maintenance - MSN
Why did GUTS stock plummet today despite positive gut therapy midterm study? - MSN
Fractyl Health (GUTS) Is Down 78.0% After Positive REMAIN-1 Midpoint Data And De Novo FDA PlanHas The Bull Case Changed? - Sahm
Fractyl Health Shares Fall After Morgan Stanley Downgrade - marketscreener.com
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Fractyl Health, Inc. Investigated on Behalf of InvestorsContact the DJS Law Group to Discuss Your Rights – GUTS - marketscreener.com
Institutional Owners May Take Dramatic Actions as Fractyl Health, Inc.'s (NASDAQ:GUTS) Recent 72% Drop Adds to One-year Losses - 富途牛牛
Fractyl Health (GUTS) Tests Whether Revita Can Redefine Post-GLP-1 Weight Maintenance Economics - Yahoo Finance
Revita treatment shows promise for weight maintenance after GLP-1 use By Investing.com - Investing.com South Africa
Morgan Stanley downgrades Fractyl Health stock rating to Equalweight on Revita trial results By Investing.com - Investing.com South Africa
Morgan Stanley downgrades Fractyl Health stock rating to Equalweight on Revita trial results - Investing.com India
What if Oprah Knew About Fractyl Health? - MedCity News
Why Is Fractyl Health Stock Tumbling Today?Fractyl Health (NASDAQ:GUTS) - Benzinga
Fractyl Health's Revita reduces post-GLP-1 weight regain by ~70% - TechTarget
Crude Oil Surges 3%; Caterpillar Shares Gain After Q4 Results - Benzinga
Fractyl Health announces compelling 6-month randomized Remain-1 midpoint data showing durable weight maintenance with Revita after GLP-1 discontinuation - marketscreener.com
Fractyl Health Showcases 6-Month REMAIN-1 Data as Revita Curbs Post-GLP-1 Weight Regain - MarketBeat
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Fractyl’s Revita reduces post-GLP-1 weight regain 70% - BioWorld MedTech
GUTS: Revita cut post-GLP-1 weight regain by 70% in high-risk patients at six months, with strong safety - TradingView
US Stocks Mixed; Tesla Posts Upbeat Q4 Earnings - Benzinga
Why Did GUTS Stock Plummet Today Despite Positive Gut Therapy Midterm Study? - Stocktwits
GUTS: Revita shows robust six-month weight maintenance post-GLP-1, supporting pivotal study success - TradingView
Fractyl Health Advances Revita for Post-GLP-1 Weight Maintenance - TipRanks
Will Fractyl Health Inc. outperform during market ralliesQuarterly Profit Summary & Safe Entry Momentum Stock Tips - mfd.ru
Fractyl Health's Revita Demonstrates Durable Weight Maintenance; Shares Fall Despite Positive Data - Nasdaq
Revita treatment shows promise for weight maintenance after GLP-1 use - Investing.com Canada
Fractyl Health Announces 6-Month REMAIN-1 Midpoint Data - TradingView
Revita trial cuts post-GLP-1 weight regain at Fractyl Health (GUTS) - stocktitan.net
Fractyl Health stock falls after midpoint data on GLP-1 weight maintenance By Investing.com - Investing.com South Africa
Fractyl Health stock falls after midpoint data on GLP-1 weight maintenance - Investing.com Canada
Fractyl Health Announces Compelling 6-Month Randomized Remain-1 Midpoint Data Showing Durable Weight Maintenance With Revita® After Glp-1 Discontinuation - TradingView
Fractyl Health Announces Compelling 6-Month Randomized REMAIN-1 Midpoint Data Showing Durable Weight Maintenance with Revita® After GLP-1 Discontinuation - The Manila Times
GUTS: Revita shows sustained weight maintenance and safety post-GLP-1, with key 2026 milestones ahead - TradingView
Fractyl Health Announces Compelling 6-Month Randomized - GlobeNewswire
Biotech Alert: Searches spiking for these stocks today - TipRanks
HC Wainwright Forecasts Fractyl Health FY2030 Earnings - MarketBeat
U.S. Bio Firms Develop Single-Injection Gene Therapies to Cure Obesity - 조선일보
The next frontier in weight-loss drugs: one-time gene therapy - The Washington Post
Volume Summary: Is Fractyl Health Inc undervalued by DCF analysis2025 Technical Patterns & Fast Gain Swing Trade Alerts - baoquankhu1.vn
Short Interest in Fractyl Health, Inc. (NASDAQ:GUTS) Expands By 24.0% - MarketBeat
What is the PEG ratio of Fractyl Health Inc.Quarterly Trade Review & Consistent Return Investment Signals - bollywoodhelpline.com
Earnings Risk: What is the dividend yield of Fractyl Health IncTrade Signal Summary & Community Supported Trade Ideas - baoquankhu1.vn
Fractyl Health Inc Stock (GUTS) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.24%
0.19%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):